# FDA Inspection 1235013 - Rachel Layman, M.D. - February 29, 2024

Source: https://www.keypedia.com/records/fda_inspections/rachel-layman-md/77821460-2e93-47e3-83c9-113877cdc228
Source feed: FDA_Inspections

> FDA Inspection 1235013 for Rachel Layman, M.D. on February 29, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1235013
- Company Name: Rachel Layman, M.D.
- Inspection Date: 2024-02-29
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/rachel-layman-md/16a7cf0b-a5a7-4968-9b7e-efd950bd6da3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c